BIOMAY was founded in Linz (cofounder: Prof. Dietrich Kraft)
1984-1988
Cloning and expression of Bet v1 as the first recombinant pollen allergen worldwide.
1988-2000
Development and production of a second recombinant birch pollen allergen, Bet v2, followed by various recombinant allergens from trees, grass, weeds, food, and latex. Development of innovative strategies for allergy therapy.
2000
Company moved from Linz and Salzburg to Vienna. Start of a clinical study (vaccine for birch pollen allergy) in centers at Straßburg, Stockholm, and Vienna.
2002-2005
License agreements signed with leading companies in the fields of diagnostics and therapy. Start of clinical studies in cooperation with strategic partners. Production of allergens for the research market.
March 2004
Company moved to new facilities in the Vienna Competence Center, near the Medical University of Vienna
Sept. 2004
Implementation of a Quality Management System (EN ISO 9001:2000)
